These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7196056

  • 1. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.
    Kayama N, Sakaguchi K, Kaneko S, Kubota T, Fukuzawa T, Kawamura S, Yoshimoto T, Yamamoto S.
    Prostaglandins; 1981 Apr; 21(4):543-54. PubMed ID: 7196056
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ.
    Br J Clin Pharmacol; 1983 Apr; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [Abstract] [Full Text] [Related]

  • 4. A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors.
    Fitzpatrick FA, Gorman RR.
    Biochim Biophys Acta; 1978 Mar 01; 539(2):162-72. PubMed ID: 629996
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.
    Tai HH, Lee N, Tai CL.
    Adv Prostaglandin Thromboxane Res; 1980 Mar 01; 6():447-52. PubMed ID: 7189951
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensions.
    Needleman P, Bryan B, Wyche A, Bronson SD, Eakins K, Ferrendelli JA, Minkes M.
    Prostaglandins; 1977 Nov 01; 14(5):897-907. PubMed ID: 594391
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products.
    Bertelé V, Falanga A, Tomasiak M, Chiabrando C, Cerletti C, de Gaetano G.
    Blood; 1984 Jun 01; 63(6):1460-6. PubMed ID: 6426554
    [Abstract] [Full Text] [Related]

  • 11. UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity.
    Randall MJ, Parry MJ, Hawkeswood E, Cross PE, Dickinson RP.
    Thromb Res; 1984 Jun 01; 23(1-2):145-62. PubMed ID: 6795753
    [No Abstract] [Full Text] [Related]

  • 12. Thromboxane synthetase inhibition as antithrombotic strategy.
    Vermylen J, Defreyn G, Carreras LO, Machin SJ, Van Schaeren J, Verstraete M.
    Lancet; 1981 May 16; 1(8229):1073-5. PubMed ID: 6112447
    [Abstract] [Full Text] [Related]

  • 13. 9,11-Iminoepoxyprosta-5,13-dienoic acid is a selective thromboxane A2 synthetase inhibitor.
    Fitzpatrick F, Gorman R, Bundy G, Honohan T, McGuire J, Sun F.
    Biochim Biophys Acta; 1979 May 25; 573(2):238-44. PubMed ID: 375987
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V, De Gaetano G.
    Eur J Pharmacol; 1982 Dec 03; 85(3-4):331-3. PubMed ID: 6295787
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD, Hamilton JG.
    Adv Prostaglandin Thromboxane Res; 1980 Dec 03; 6():453-6. PubMed ID: 6770605
    [No Abstract] [Full Text] [Related]

  • 18. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Dec 03; 11():235-40. PubMed ID: 6221529
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platelet thromboxane synthetase inhibitors with low doses of aspirin: possible resolution of the "aspirin dilemma".
    Bertelé V, Falanga A, Tomasiak M, Dejana E, Cerletti C, de Gaetano G.
    Science; 1983 Apr 29; 220(4596):517-9. PubMed ID: 6682245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.